US EditionPortal Access secures $7M for chemotherapy port
Summary by MobiHealthNews
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Portal Access secures $7M for chemotherapy port
Portal Access, an oncology-focused medical device startup, closed a $7 million Series A financing round. The company said that more than 80% of the round was led by U.S. physician investors, including oncologists, interventional radiologists, cardiologists and vascular surgeons. Additional investors include a partnership from an unnamed U.S.-based venture capital fund. WHAT IT DOES The company manufactures Flexi-Port SLF-TANL, a subcutaneous por…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
